Abouleish E, Wingard L B, de la Vega S, Uy N
Br J Anaesth. 1980 May;52(5):531-6. doi: 10.1093/bja/52.5.531.
Pancuronium bromide was used in 49 patients undergoing repeat elective Caesarean section. In 26 patients who received only pancuronium 0.1 mg kg-1, pancuronium was detected in all umbilical venous or arterial samples (0.12 micrograms ml-1). In 23 other patiets who received suxamethonium 1.0 mg kg-1 followed by pancuronium 0.05 mg kg-1, pancuronium was detected in fetal blood 2 min after injection; the concentration of pancuronium in umbilical venous or arterial samples in 14 subjects was 0.08 micrograms ml-1, and less than 0.05 micrograms ml-1 in nine subjects. There was no evidence that such concentrations of pancuronium were detrimental to the fetus. The use of suxamethonium before pancuronium resulted in reduction of pancuronium dosage, induction-delivery time, and fetal concentrations of pancuronium, and was associated with better condition of the neonate.
49例接受择期再次剖宫产的患者使用了潘库溴铵。在仅接受0.1mg/kg潘库溴铵的26例患者中,所有脐静脉或动脉样本中均检测到潘库溴铵(0.12μg/ml)。在另外23例接受1.0mg/kg琥珀胆碱随后0.05mg/kg潘库溴铵的患者中,注射后2分钟在胎儿血液中检测到潘库溴铵;14例受试者脐静脉或动脉样本中潘库溴铵浓度为0.08μg/ml,9例受试者中低于0.05μg/ml。没有证据表明这种浓度的潘库溴铵对胎儿有害。在潘库溴铵之前使用琥珀胆碱可减少潘库溴铵剂量、诱导-分娩时间以及胎儿体内潘库溴铵浓度,并与新生儿状况改善相关。